BioSpace News Archive

Sciad Newswire / Hypha Discovery Limited, a leading microbial biotechnology company specialising in biocatalytic solutions for pharmaceutical and agricultural R&D companies, has launched its new line of PolyCYPs® kits

Finalists to Compete for More Than $1.8 Million in Oldest and Most Prestigious U.S. STEM Competition for High School Seniors

New technology offers ability to tune device remotely and connect with an audiologist via smartphone app, impacting millions affected by hearing loss who can now receive treatment from home

Appointment bolsters Neurogene’s mission to bring life-changing therapies to patients with rare neurological disorders

World-Renowned Expert Assumes New Leadership Role at VDI

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to lead product candidate A4250, an ileal bile acid transporter (IBAT) inhibitor, for the treatment of biliary atresia, a rare and life-threatening liver disease with no approved pharmacologic treatment option.

Foster Corporation, a leader in polymer solutions for medical device and pharmaceutical applications, introduces LazerMed™, a biocompatible laser marking technology that offers high resolution, durable printing capability for plastic materials used in medical devices such as tubing, catheter shafts, labware, and medical equipment.

Natural Alternatives International, Inc. today announced its participation in the 15th edition of the Integrative Healthcare Symposium

Government Marketing & Procurement, LLC (GMP) announced today the recent award of a VA Federal Supply System Schedule 65IIA (Medical Equipment and Supplies) contract.

Aquila, a full-service, on-site health, fitness and wellbeing management group, announced today that it has been selected as winner in four categories of the ACQ5 2018 Global Awards by ACQ5.